Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1992 Jun;88(3):512–519. doi: 10.1111/j.1365-2249.1992.tb06480.x

Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation.

J E Lortan 1, A Vellodi 1, E S Jurges 1, K Hugh-Jones 1
PMCID: PMC1554526  PMID: 1606736

Abstract

Immunoglobulin class- and subclass-specific antibodies to a polyvalent pneumococcal capsular polysaccharide vaccine (Pneumovax II) were measured before and after immunization in children, 1 year or more after bone marrow transplantation for a variety of genetic disorders. The median titres of specific IgG, IgG1 and IgG2 pneumococcal antibodies fell significantly (P less than 0.05) from pre-transplantation levels. The levels of pneumococcal antibodies in the patients before immunization were markedly lower than those in control children of comparable age, for antibodies of IgM, IgG, IgG1 and IgG2 classes (P = less than 0.001 in each case). Apart from IgG2 antibodies, the median response to immunization with Pneumovax II was not significantly different from the controls (P greater than 0.05). However, because of the lower pre-immunization levels, the patients did not achieve a high post-immunization-specific antibody titre in any immunoglobulin class or subclass, when compared with normal children. Neither the pre-immunization specific antibody levels nor the response to immunization were affected by splenectomy or the presence of chronic graft-versus-host disease. Immunization of the donor before bone marrow harvest did not influence the level of specific antibody 1 year or more after transplantation. No significant correlation was found between the total serum IgG2, the patients' age at the time of assessment, or time after transplantation, and the IgG2-specific antibody response. The lack of specific antibodies and the poor IgG2 response to pneumococcal antigens may contribute towards the occurrence of infection with Streptococcus pneumoniae in the late post-transplantation period.

Full text

PDF
512

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amlot P. L., Hayes A. E. Impaired human antibody response to the thymus-independent antigen, DNP-Ficoll, after splenectomy. Implications for post-splenectomy infections. Lancet. 1985 May 4;1(8436):1008–1011. doi: 10.1016/s0140-6736(85)91613-7. [DOI] [PubMed] [Google Scholar]
  2. Barrett D. J., Ayoub E. M. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol. 1986 Jan;63(1):127–134. [PMC free article] [PubMed] [Google Scholar]
  3. Bird P., Lowe J., Stokes R. P., Bird A. G., Ling N. R., Jefferis R. The separation of human serum IgG into subclass fractions by immunoaffinity chromatography and assessment of specific antibody activity. J Immunol Methods. 1984 Jun 8;71(1):97–105. doi: 10.1016/0022-1759(84)90209-6. [DOI] [PubMed] [Google Scholar]
  4. Briles D. E., Claflin J. L., Schroer K., Forman C. Mouse Igg3 antibodies are highly protective against infection with Streptococcus pneumoniae. Nature. 1981 Nov 5;294(5836):88–90. doi: 10.1038/294088a0. [DOI] [PubMed] [Google Scholar]
  5. Brown M., Schiffman G., Rittenberg M. B. Subpopulations of antibodies to phosphocholine in human serum. J Immunol. 1984 Mar;132(3):1323–1328. [PubMed] [Google Scholar]
  6. Chudwin D. S., Wara D. W., Lameris-Martin N. B., Ammann A. J. Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19. Proc Soc Exp Biol Med. 1983 Feb;172(2):178–186. doi: 10.3181/00379727-172-41543. [DOI] [PubMed] [Google Scholar]
  7. Cohn D. A., Schiffman G. Immunoregulatory role of the spleen in antibody responses to pneumococcal polysaccharide antigens. Infect Immun. 1987 Jun;55(6):1375–1380. doi: 10.1128/iai.55.6.1375-1380.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Evans D. I. Postsplenectomy sepsis 10 years or more after operation. J Clin Pathol. 1985 Mar;38(3):309–311. doi: 10.1136/jcp.38.3.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Freijd A., Hammarström L., Persson M. A., Smith C. I. Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children. Clin Exp Immunol. 1984 May;56(2):233–238. [PMC free article] [PubMed] [Google Scholar]
  10. Giebink G. S., Warkentin P. I., Ramsay N. K., Kersey J. H. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. J Infect Dis. 1986 Oct;154(4):590–596. doi: 10.1093/infdis/154.4.590. [DOI] [PubMed] [Google Scholar]
  11. Givner L. B., Baker C. J., Edwards M. S. Type III group B Streptococcus: functional interaction with IgG subclass antibodies. J Infect Dis. 1987 Mar;155(3):532–539. doi: 10.1093/infdis/155.3.532. [DOI] [PubMed] [Google Scholar]
  12. Gray D., Chassoux D., MacLennan I. C., Bazin H. Selective depression of thymus-independent anti-DNP antibody responses induced by adult but not neonatal splenectomy. Clin Exp Immunol. 1985 Apr;60(1):78–86. [PMC free article] [PubMed] [Google Scholar]
  13. Hammarström L., Smith C. I. Development of anti-polysaccharide antibodies in asplenic children. Clin Exp Immunol. 1986 Nov;66(2):457–462. [PMC free article] [PubMed] [Google Scholar]
  14. Hobbs J. R., Hugh-Jones K., Shaw P. J., Downie C. J., Williamson S. Engraftment rates related to busulphan and cyclophosphamide dosages for displacement bone marrow transplants in fifty children. Bone Marrow Transplant. 1986 Dec;1(2):201–208. [PubMed] [Google Scholar]
  15. Hobbs J. R., Jones K. H., Shaw P. J., Lindsay I., Hancock M. Beneficial effect of pre-transplant splenectomy on displacement bone marrow transplantation for Gaucher's syndrome. Lancet. 1987 May 16;1(8542):1111–1115. doi: 10.1016/s0140-6736(87)91673-4. [DOI] [PubMed] [Google Scholar]
  16. Jefferis R., Reimer C. B., Skvaril F., de Lange G., Ling N. R., Lowe J., Walker M. R., Phillips D. J., Aloisio C. H., Wells T. W. Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. Immunol Lett. 1985;10(3-4):223–252. doi: 10.1016/0165-2478(85)90082-3. [DOI] [PubMed] [Google Scholar]
  17. KING H., SHUMACKER H. B., Jr Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy. Ann Surg. 1952 Aug;136(2):239–242. doi: 10.1097/00000658-195208000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kiroff G. K., Hodgen A. N., Drew P. A., Jamieson G. G. Lack of effect of splenic regrowth on the reduced antibody responses to pneumococcal polysaccharides in splenectomized patients. Clin Exp Immunol. 1985 Oct;62(1):48–56. [PMC free article] [PubMed] [Google Scholar]
  19. Lane P. J., MacLennan I. C. Impaired IgG2 anti-pneumococcal antibody responses in patients with recurrent infection and normal IgG2 levels but no IgA. Clin Exp Immunol. 1986 Aug;65(2):427–433. [PMC free article] [PubMed] [Google Scholar]
  20. Lawrence E. M., Edwards K. M., Schiffman G., Thompson J. M., Vaughn W. K., Wright P. F. Pneumococcal vaccine in normal children. Primary and secondary vaccination. Am J Dis Child. 1983 Sep;137(9):846–850. doi: 10.1001/archpedi.1983.02140350024007. [DOI] [PubMed] [Google Scholar]
  21. Lowdon A. G., Stewart R. H., Walker W. Risk of serious infection following splenectomy. Br Med J. 1966 Feb 19;1(5485):446–450. doi: 10.1136/bmj.1.5485.446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Oldfield S., Jenkins S., Yeoman H., Gray D., MacLennan I. C. Class and subclass anti-pneumococcal antibody responses in splenectomized patients. Clin Exp Immunol. 1985 Sep;61(3):664–673. [PMC free article] [PubMed] [Google Scholar]
  23. Persson M. A., Hammarström L., Smith C. I. Enzyme-linked immunosorbent assay for subclass distribution of human IgG and IgA antigen-specific antibodies. J Immunol Methods. 1985 Apr 8;78(1):109–121. doi: 10.1016/0022-1759(85)90334-5. [DOI] [PubMed] [Google Scholar]
  24. Rosse W. F. The spleen as a filter. N Engl J Med. 1987 Sep 10;317(11):704–706. doi: 10.1056/NEJM198709103171110. [DOI] [PubMed] [Google Scholar]
  25. Rynnel-Dagö B., Freijd A., Hammarström L., Oxelius V., Persson M. A., Smith C. I. Pneumococcal antibodies of different immunoglobulin subclasses in normal and IgG subclass deficient individuals of various ages. Acta Otolaryngol. 1986 Jan-Feb;101(1-2):146–151. doi: 10.3109/00016488609108617. [DOI] [PubMed] [Google Scholar]
  26. Shulman H. M., Sullivan K. M., Weiden P. L., McDonald G. B., Striker G. E., Sale G. E., Hackman R., Tsoi M. S., Storb R., Thomas E. D. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980 Aug;69(2):204–217. doi: 10.1016/0002-9343(80)90380-0. [DOI] [PubMed] [Google Scholar]
  27. Siber G. R., Schur P. H., Aisenberg A. C., Weitzman S. A., Schiffman G. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med. 1980 Jul 24;303(4):178–182. doi: 10.1056/NEJM198007243030402. [DOI] [PubMed] [Google Scholar]
  28. Windebank K. P., Faux J. A., Chapel H. M. ELISA determination of IgG antibodies to pneumococcal capsular polysaccharides in a group of children. J Immunol Methods. 1987 Nov 23;104(1-2):143–148. doi: 10.1016/0022-1759(87)90498-4. [DOI] [PubMed] [Google Scholar]
  29. Winston D. J., Ho W. G., Schiffman G., Champlin R. E., Feig S. A., Gale R. P. Pneumococcal vaccination of recipients of bone marrow transplants. Arch Intern Med. 1983 Sep;143(9):1735–1737. [PubMed] [Google Scholar]
  30. Winston D. J., Schiffman G., Wang D. C., Feig S. A., Lin C. H., Marso E. L., Ho W. G., Young L. S., Gale R. P. Pneumococcal infections after human bone-marrow transplantation. Ann Intern Med. 1979 Dec;91(6):835–841. doi: 10.7326/0003-4819-91-6-835. [DOI] [PubMed] [Google Scholar]
  31. Witherspoon R. P., Storb R., Ochs H. D., Fluornoy N., Kopecky K. J., Sullivan K. M., Deeg J. H., Sosa R., Noel D. R., Atkinson K. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood. 1981 Aug;58(2):360–368. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES